Research results show that vaccination reduces the chance of heart attack or stroke after new corona by 41%



Developing a new type of coronavirus infection (COVID-19) is known to increase the long-term risk of causing cardiovascular diseases such as heart attack and stroke. However, a newly published study points out that those who have been vaccinated are at reduced risk.

Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection | Journal of the American College of Cardiology

https://doi.org/10.1016/j.jacc.2022.12.006

The study, led by researchers at the Icahn School of Medicine Mount Sinai in New York, found that more than 1.9 million patients infected with the novel coronavirus (SARS-CoV-2) between March 2020 and February 2022 Medical records were examined. Of those patients, 13,948 had 'cardiac adverse events ' of heart attack, stroke, or other heart disease, followed by 3,175 deaths.

Overall, researchers found that people who completed vaccination or received at least one dose had a reduced rate of developing cardiovascular disease six months after a case of COVID-19 Did. After adjusting for demographics, comorbidities, and time since the outbreak of the pandemic, complete vaccination reduced the risk of developing major heart disease by approximately 41%, while having even one dose of the vaccine reduced the risk. We found that it decreased by about 24%.



In the event of major heart disease, the median date of onset was 17 days after onset of COVID-19 infection and 212 days after last vaccination. Overall, regardless of vaccination, men, the elderly, and those with other underlying medical conditions had the highest risk of cardiac events after infection. Having a history of heart disease was the greatest risk factor, but diabetes, liver disease, obesity and high cholesterol were also important risk factors.

“We were surprised that even partial vaccination reduced the risk of developing a major cardiac event,” said Joy Jiang, lead author of the study. “Given the growing number of SARS-CoV-2 infections around the world, we hope that our findings will help improve vaccination rates, especially among those with co-morbid conditions.” I will,” he adds.

in Science, Posted by log1p_kr